Vasoactive peptide release in the extracerebral circulation of humans during migraine headache


  • Dr P. J. Goadsby MD, PhD,

    Corresponding author
    1. Department of Neurology, The Prince Henry and Prince of Wales Hospitals, and the School of Medicine, University of New South Wales, Sydney, Australia
    • Department of Neurology, Clinical Sciences Building, The Prince Henry Hospital, Little Bay, NSW 2036 Australia
    Search for more papers by this author
  • L. Edvinsson MD, PhD,

    1. Department of Internal Medicine, University of Lund, Lund, Sweden
    Search for more papers by this author
  • R. Ekman MD

    1. Department of Neurochemistry, University of Lund, Lund, Sweden
    Search for more papers by this author


The innervation of the cranial vessels by the trigeminal nerve, the trigeminovascular system, has recently been the subject of study in view of its possible role in the mediation of some aspects of migraine. Since stimulation of the trigeminal ganglion in humans leads to facial pain and flushing and associated release of powerful neuropeptide vasodilator substances, their local release into the extracerebral circulation of humans was determined in patients who had either common or classic migraine. Venous blood was sampled from both the external jugular and the cubital fossa ipsilateral to the side of headache. Plasma levels of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide were determined using sensitive radioimmunoassays for each peptide, and values for the cubital fossa and external jugular and a control population were compared. A substantial elevation of the calcitonin gene-related peptide level in the external jugular but not the cubital fossa blood was seen in both classic and common migraine. The increase seen in classic migraine was greater than that seen with common migraine. The other peptides measured were unaltered. This finding may have importance in the pathophysiology of migraine.